HLN
Price
$10.25
Change
-$0.01 (-0.10%)
Updated
Jul 3 closing price
Capitalization
38.4B
27 days until earnings call
HLUBF
Price
$3.70
Change
+$0.04 (+1.09%)
Updated
Apr 14 closing price
Capitalization
4.85B
Interact to see
Advertisement

HLN vs HLUBF

Header iconHLN vs HLUBF Comparison
Open Charts HLN vs HLUBFBanner chart's image
Haleon
Price$10.25
Change-$0.01 (-0.10%)
Volume$8.42M
Capitalization38.4B
H. Lundbeck A/S
Price$3.70
Change+$0.04 (+1.09%)
Volume$810
Capitalization4.85B
HLN vs HLUBF Comparison Chart in %
Loading...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLN vs. HLUBF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLN is a Buy and HLUBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (HLN: $10.25 vs. HLUBF: $3.70)
Brand notoriety: HLN and HLUBF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLN: 53% vs. HLUBF: 100%
Market capitalization -- HLN: $38.4B vs. HLUBF: $4.85B
HLN [@Pharmaceuticals: Other] is valued at $38.4B. HLUBF’s [@Pharmaceuticals: Other] market capitalization is $4.85B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLN’s FA Score shows that 0 FA rating(s) are green whileHLUBF’s FA Score has 1 green FA rating(s).

  • HLN’s FA Score: 0 green, 5 red.
  • HLUBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HLN and HLUBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLN’s TA Score shows that 4 TA indicator(s) are bullish while HLUBF’s TA Score has 2 bullish TA indicator(s).

  • HLN’s TA Score: 4 bullish, 6 bearish.
  • HLUBF’s TA Score: 2 bullish, 0 bearish.
According to our system of comparison, both HLN and HLUBF are a good buy in the short-term.

Price Growth

HLN (@Pharmaceuticals: Other) experienced а -1.63% price change this week, while HLUBF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

HLN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($38.4B) has a higher market cap than HLUBF($4.85B). HLN has higher P/E ratio than HLUBF: HLN (29.23) vs HLUBF (11.95). HLN YTD gains are higher at: 8.671 vs. HLUBF (-16.479). HLUBF has higher annual earnings (EBITDA): 2.94B vs. HLN (2.35B). HLUBF has more cash in the bank: 2.88B vs. HLN (994M). HLUBF has less debt than HLN: HLUBF (5.22B) vs HLN (9.46B). HLUBF has higher revenues than HLN: HLUBF (18.9B) vs HLN (11.3B).
HLNHLUBFHLN / HLUBF
Capitalization38.4B4.85B792%
EBITDA2.35B2.94B80%
Gain YTD8.671-16.479-53%
P/E Ratio29.2311.95245%
Revenue11.3B18.9B60%
Total Cash994M2.88B34%
Total Debt9.46B5.22B181%
TECHNICAL ANALYSIS
Technical Analysis
HLNHLUBF
RSI
ODDS (%)
Bullish Trend 1 day ago
53%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
59%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
35%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
39%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
46%
Bullish Trend 1 day ago
25%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
36%
Bullish Trend 1 day ago
32%
Advances
ODDS (%)
Bullish Trend 22 days ago
59%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
48%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
60%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
40%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CNRG64.982.60
+4.18%
SPDR® Kensho Clean Power ETF
PFH17.560.07
+0.40%
Prudential Financial
KHYB24.000.04
+0.15%
KraneShares Asia Pacific Hi Inc USD ETF
ANGL29.18-0.01
-0.03%
VanEck Fallen Angel HiYld Bd ETF
RSPG76.35-0.03
-0.04%
Invesco S&P 500® Equal Weight Energy ETF

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
-0.10%
HLNCF - HLN
49%
Loosely correlated
-5.74%
TAK - HLN
37%
Loosely correlated
-0.52%
ZTS - HLN
29%
Poorly correlated
+0.06%
BHC - HLN
25%
Poorly correlated
-0.84%
HCM - HLN
25%
Poorly correlated
+0.76%
More

HLUBF and

Correlation & Price change

A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
HLBBF - HLUBF
18%
Poorly correlated
N/A
HLNCF - HLUBF
7%
Poorly correlated
-5.74%
ESAIY - HLUBF
5%
Poorly correlated
+0.28%
AKAN - HLUBF
2%
Poorly correlated
+5.38%
HLN - HLUBF
1%
Poorly correlated
-0.10%
More